Contract Pharma Manufacturing News

  1. Atombeat And BioDuro Announce Strategic Partnership To Launch An AI-Powered Platform For Accelerated Peptide Drug Discovery 8/1/2025

    On July 30, 2025, Atombeat Inc., a leading force in AI for drug discovery, and BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organization (CRDMO), announced a strategic collaboration to an AI powered platform for accelerated peptide drug discovery.

  2. Mallinckrodt, Endo Complete Merger To Create Global, Scaled, Diversified Therapeutics Leader 8/1/2025

    Mallinckrodt plc and Endo, Inc. today announced that they have completed their merger to create a global, scaled, diversified therapeutics leader.

  3. Repligen Announces Strategic Partnership With Novasign To Further Advance Bioprocessing Digitalization 7/31/2025

    Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced Novasign and Repligen have entered into a strategic partnership to develop and integrate Novasign’s machine learning and modeling workflow into Repligen filtration systems.

  4. Psyence BioMed's Strategic Collaboration With PsyLabs Yields Breakthrough In High-Purity Ibogaine Production 7/31/2025

    Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”) is pleased to announce that its strategic partner, PsyLabs – a leader in the production of purified psychedelic compounds – has successfully produced a GMP-aligned Ibogaine Total Alkaloid extract.

  5. PL BioScience Announces Major Site Expansion 7/31/2025

    PL BioScience GmbH, a German life science company specializing in the production and development of Human Platelet Lysate (HPL) for cell expansion, today announced a significant expansion of company headquarters and future manufacturing capabilities to meet the rapidly growing global demand for safe, animal-free cell culture supplements.

  6. ESTEVE CDMO Acquires Regis Technologies, Expanding U.S. Presence And Capabilities 7/31/2025

    ESTEVE acquires Regis Technologies, a United States-based Contract Development and Manufacturing Organization (CDMO), headquartered in Chicago.

  7. Dr. Falk Pharma And Allianthera (Suzhou) Biopharmaceuticals Forge Strategic Partnership For Novel AhR Agonist Development 7/30/2025

    Dr. Falk Pharma GmbH and Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Announce Strategic Partnership to Develop a Novel AhR Agonist for the Treatment of Moderate to Severe Ulcerative Colitis

  8. Sandoz Signs Non-Binding Term Sheet With Evotec SE To Acquire Its Just-Evotec Biologics In-House Development And Manufacturing Capabilities In Toulouse, France 7/30/2025

    Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, announced today that it has signed a non-binding term sheet with Evotec SE.

  9. Bio Usawa Biotechnology And Sartorius Stedim Biotech Forge Partnership To Pioneer Biopharmaceutical Manufacturing In Africa 7/29/2025

    Bio Usawa Biotechnology, Ltd. (Bio Usawa), a leading African biotechnology firm, and Sartorius Stedim Biotech, a global partner of biopharmaceutical manufacturing, have announced a partnership to accelerate Africa’s biopharmaceutical industry and address the continent’s urgent, dual health burdens in infectious and non-communicable diseases.

  10. WuXi Biologics Singapore CRDMO Hub Advances With The Launch Of Modular Drug Product Facility Fabrication 7/29/2025

    WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced construction has begun for a new modular Drug Product (DP) facility, which will become part of the company's CRDMO hub in Singapore.